Target intelligence / Profile preview

Double homeobox A pseudogene 11 (DUXAP11)

Target
DUXAP11
Molecular classification
Other (pseudogene, non-coding RNA)
01

Overview

Double homeobox A pseudogene 11 (DUXAP11) is annotated as a pseudogene and presumed non-coding RNA, but there is currently no primary literature or curated data describing its molecular function, biology, or clinical significance. No evidence identifies DUXAP11 as a therapeutic target or biomarker, and it should not be confused with functionally characterized loci such as DUX4 or the related pseudogene DUXAP10, which have established roles in cancer. Additionally, DUXAP11 is sometimes misreported in literature databases due to the similarity of pseudogene names; no current data link DUXAP11 to any disease process or druggability. Key notes: - DUXAP11 is a pseudogene; its transcript has not been functionally characterized, and there are no known molecular or pharmacological roles. - Do not confuse DUXAP11 with DUXAP10, which is a lncRNA pseudogene under active research in oncology. - No clinical, therapeutic, or biomarker use of DUXAP11 has been established to date. - This entry is likely to have incomplete or missing information for most structured fields due to its uncharacterized status.

Other names
double homeobox A pseudogene 11DUXAP11
02

Biological functions

Unknown (no published functional characterization)
03

Disease associations

None established (no disease or pharmacological relevance reported)

Beyond the preview

Go deeper on Double homeobox A pseudogene 11 (DUXAP11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Double homeobox A pseudogene 11 (DUXAP11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call